Tech Company Financing Transactions
Primrose Bio Funding Round
Primrose Bio closed a financing round on 9/22/2026. Investors included Signet Healthcare Partners, 1315 Capital and Agent Capital.
Transaction Overview
Company Name
Announced On
9/22/2026
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to continue to expand the reach and capabilities of its technology portfolio.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
10790 Roselle St
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Overview
Primrose Bio offers radically new products and tools that unlock unexplored possibilities for the discovery, development, and manufacturing of new molecules. Our mission is to enable the development of innovative therapeutics, vaccines and ingredients to advance global health.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Drew Burch
Chief Financial Officer
Simon Latimer
Controller
Marc Ayres
President
Diane Retallack
Vice President
Jeff Allen
VP - Bus. Development
Louis Cantolupo
VP - Engineering
Russell Coleman
VP - Operations
Bill Colby
VP - Product Management
Jennifer Wittbold
Browse more venture capital transactions:
Prev: 9/22/2026: Molecular Targeting Technologies (MTTI) venture capital transaction
Next: 9/22/2026: Bird&Be venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. VC transactions reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs